Why Novocure Stock Is Jumping Today
Shares of Novocure Limited (NASDAQ: NVCR) are jumping 12.9% higher as of 11:09 a.m. ET on Thursday. The solid gain came after investment firm Truist Financial upgraded the stock from a hold to a buy recommendation. Truist kept its 12-month price target for the stock at $125, which represents upside potential of more than 70%.
Should investors buy Novocure because one analyst is more upbeat about its prospects? No. However, there are some compelling reasons Truist upgraded the healthcare stock to a buy recommendation.
Image source: Getty Images.
Source Fool.com